Table 1. Summary of Screen Hits.
Compound | Target | Approx. IC50 (µM) | Mechanism |
Novobiocin | DNA gyrase | N.D.* | Aminocoumarin ATPase inhibitor |
Acriflavinium | DNA gyrase | N.D.* | ATPase inhibitor |
Ciprofloxacin | DNA gyrase | N.D.* | Fluoroquinolone cleavage-complex stabiliser |
Gatifloxacin | DNA gyrase | N.D.* | Fluoroquinolone cleavage-complex stabiliser |
Levofloxacin | DNA gyrase | N.D.* | Fluoroquinolone cleavage-complex stabiliser |
Lomefloxacin | DNA gyrase | N.D.* | Fluoroquinolone cleavage-complex stabiliser |
Moxifloxacin | DNA gyrase | N.D.* | Fluoroquinolone cleavage-complex stabiliser |
Norfloxacin | DNA gyrase | N.D.* | Fluoroquinolone cleavage-complex stabiliser |
Ofloxacin | DNA gyrase | N.D.* | Fluoroquinolone cleavage-complex stabiliser |
Perfloxacine Mesylate | DNA gyrase | N.D.* | Fluoroquinolone cleavage-complex stabiliser |
Surafloxacin | DNA gyrase | N.D.* | Fluoroquinolone cleavage-complex stabiliser |
Mitoxantrone | DNA gyrase/Topo VI | 12/2 | Cleavage-complex stabiliser/Prevents cleavage |
Suramin | DNA gyrase/Topo VI | 80/30 | Blocks DNA binding |
Purpurin | Topo VI | 40 | Blocks DNA binding |
9-Aminoacridne | Topo VI | 6 | Prevents DNA cleavage |
Quinacrine | Topo VI | 8 | Prevents DNA cleavage |
m-Amsacrine | Topo VI | 30 | Prevents DNA cleavage |
Hexylresorcinol | Topo VI | 30 | Unknown |
Not determined in this study.